Advanced Enzyme Technologies LtdNSE: ADVENZYMES

Press Release Sep 13 2021

· Issued by Advanced Enzyme Technologies Ltd

Filed with NSE · · 19 pages · English and Hindi

Summary by 6ix AI

Advanced Enzyme Technologies Ltd has announced a positive clinical breakthrough in randomized controlled trials involving systemic enzymes and probiotics aimed at alleviating long COVID fatigue symptoms. The trials involved two groups of patients, with one receiving the supplements and the other a placebo, showing significant efficacy in reducing fatigue.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Advanced Enzyme Technologies Limited has informed the Exchange regarding a press release dated September 13, 2021, titled " Advanced Enzymes announces Positive Clinical Breakthrough in the Randomized Controlled Trials of Systemic Enzymes and Probiotics to Resolve Long Covid Fatigue Symptoms ".

Advanced Enzyme Technologies Ltd on 6ix

Earlier from Advanced Enzyme Technologies

Later from Advanced Enzyme Technologies

All Advanced Enzyme Technologies news releases